|
(2R,3R,4R,5R)-2-[(1S,2S,3R,4S,6R)-4,6-diamino-3-[(2R,3R,6S)-3-amino-6-[(1R)-1-aminoethyl]oxan-2-yl]oxy-2-hydroxy-cyclohexyl]oxy-5-methyl-4-methylamino-oxane-3,5-diol Suppliers list
|
|
| | (2R,3R,4R,5R)-2-[(1S,2S,3R,4S,6R)-4,6-diamino-3-[(2R,3R,6S)-3-amino-6-[(1R)-1-aminoethyl]oxan-2-yl]oxy-2-hydroxy-cyclohexyl]oxy-5-methyl-4-methylamino-oxane-3,5-diol Basic information |
| Product Name: | (2R,3R,4R,5R)-2-[(1S,2S,3R,4S,6R)-4,6-diamino-3-[(2R,3R,6S)-3-amino-6-[(1R)-1-aminoethyl]oxan-2-yl]oxy-2-hydroxy-cyclohexyl]oxy-5-methyl-4-methylamino-oxane-3,5-diol | | Synonyms: | (2R,3R,4R,5R)-2-[(1S,2S,3R,4S,6R)-4,6-diamino-3-[(2R,3R,6S)-3-amino-6-[(1R)-1-aminoethyl]oxan-2-yl]oxy-2-hydroxy-cyclohexyl]oxy-5-methyl-4-methylamino-oxane-3,5-diol;4-O-(2-Amino-2,3,4,6,7-pentadeoxy-6-amino-α-D-ribo-heptopyranosyl)-6-O-(3-deoxy-4-methyl-3-methylamino-β-L-arabinopyranosyl)-2-deoxy-D-streptamine;Gentamycin Sulfate Impurity 9;Gentamicin Sulfate Impurity II:(2R,3R,4R,5R)-2-[(1S,2S,3R,4S,6R)-4,6-diamino-3-[(2R,3R,6S)-3-amino-6-[(1R)-1-aminoethyl]oxan-2-yl]oxy-2-hydroxy-cyclohexyl]oxy-5-methyl-4-methylamino-oxane-3,5-diol;Gentamicin C2 sulfate;6-O-(3-Deoxy-4-methyl-3-methylamino-β-L-arabinopyranosyl)-4-O-(2,6-diamino-2,3,4,6,7-pentadeoxy-α-D-ribo-heptopyranosyl)-2-deoxy-D-streptamine;Gentamicin C2 Pentaacetate Salt;O-3-Deoxy-4-C-Methyl-3-(MethylaMino)-β-L-arabinopyranosyl-(16)-O-[2,6-diaMino-2,3,4,6,7-pentadeoxy-α-D-ribo-heptopyranosyl-(14)]-2-deoxy- | | CAS: | 25876-11-3 | | MF: | C20H41N5O7 | | MW: | 463.57 | | EINECS: | | | Product Categories: | Inhibitors;Intermediates & Fine Chemicals;Oligosaccharides;Pharmaceuticals | | Mol File: | 25876-11-3.mol | ![(2R,3R,4R,5R)-2-[(1S,2S,3R,4S,6R)-4,6-diamino-3-[(2R,3R,6S)-3-amino-6-[(1R)-1-aminoethyl]oxan-2-yl]oxy-2-hydroxy-cyclohexyl]oxy-5-methyl-4-methylamino-oxane-3,5-diol Structure](CAS/GIF/25876-11-3.gif) |
| | (2R,3R,4R,5R)-2-[(1S,2S,3R,4S,6R)-4,6-diamino-3-[(2R,3R,6S)-3-amino-6-[(1R)-1-aminoethyl]oxan-2-yl]oxy-2-hydroxy-cyclohexyl]oxy-5-methyl-4-methylamino-oxane-3,5-diol Chemical Properties |
| Melting point | 104-107°C | | alpha | D25 +160° | | Boiling point | 676.3±55.0 °C(Predicted) | | density | 1.33±0.1 g/cm3(Predicted) | | storage temp. | -20°C Freezer, Under Inert Atmosphere | | pka | 13.29±0.70(Predicted) |
| | (2R,3R,4R,5R)-2-[(1S,2S,3R,4S,6R)-4,6-diamino-3-[(2R,3R,6S)-3-amino-6-[(1R)-1-aminoethyl]oxan-2-yl]oxy-2-hydroxy-cyclohexyl]oxy-5-methyl-4-methylamino-oxane-3,5-diol Usage And Synthesis |
| Chemical Properties | Light Beige Solid | | Uses | Antibacterial. A mixture of Gentamicin C2 and Gentamycin C2a. | | Uses | Antibiotic complex consists of three closely related components, gentamicins C1, C2, C1a, and also Gentamicin A which differs from the other members of the complex but is similar to Kanamycin C. Antibacterial. |
| | (2R,3R,4R,5R)-2-[(1S,2S,3R,4S,6R)-4,6-diamino-3-[(2R,3R,6S)-3-amino-6-[(1R)-1-aminoethyl]oxan-2-yl]oxy-2-hydroxy-cyclohexyl]oxy-5-methyl-4-methylamino-oxane-3,5-diol Preparation Products And Raw materials |
|